{"disease":{"id":"hepatocellular-malignancy","name":"hepatocellular malignancy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06960031","title":"Added Value of PET/CT in Assessment of Hepatocellular Malignancy Post Radiofrequency Ablation","phase":"","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Tanta University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}